By Hank Schultz, Elaine Watson and Elizabeth Crawford
A report on CBD delivered by FDA Commissioner Dr Stephen Hahn, MD, was seen by food and dietary supplement industry stakeholders as offering little hope of a timely regulatory solution for the ingredient.
FDA Commissioner Dr Stephen Hahn, MD, in a speech on Wednesday, said that despite its continued concern about insufficient safety data, the FDA has no plans to try to shut down the CBD markets. Hahn said that would amount to a “fool’s game.”